Edwards Lifesciences Corp. buy Morgan Stanley
Start price
21.03.24
/
50%
€87.56
Target price
21.03.25
€94.82
Performance (%)
-27.71%
Price
30.08.24
€63.30
Summary
This prediction is currently active. The price of Edwards Lifesciences Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -27.71%. This prediction currently runs until 21.03.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Edwards Lifesciences Corp. | -0.047% | -0.047% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Morgan_Stanley for this prediction
In the thread Edwards Lifesciences Corp. diskutieren
Edwards Lifesciences Co. (NYSE: EW) had its price target raised by analysts at Morgan Stanley from $95.00 to $103.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat
Stopped prediction by Morgan_Stanley for Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€80.38
07.02.24
07.02.24
€88.17
07.02.25
07.02.25
-21.25%
30.08.24
30.08.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€64.46
04.12.23
04.12.23
€73.97
04.12.24
04.12.24
-1.80%
30.08.24
30.08.24
Edwards Lifesciences Corp.
Start price
Target price
Perf. (%)
€83.74
14.07.23
14.07.23
€90.71
14.07.24
14.07.24
-0.53%
15.07.24
15.07.24